As a synthetic analogue of luteinizing hormone-releasing hormone (LHRH), gonadorelin is a critical peptide hormone that mimics the natural GnRH produced in the hypothalamus. Its structure, a sequence of ten amino acids, enables binding to specific receptors on pituitary gonadotropic cells. By stimulating these receptors, gonadorelin enhances the release of LH and FSH, crucial hormones for reproductive function. In therapeutic contexts, continuous gonadorelin administration inhibits gonadotropin secretion through cellular desensitization. Its applications include managing hypothalamic amenorrhea and diagnosing hypothalamic-pituitary disorders, showcasing its dual role in hormonal therapy and diagnostic evaluation.
National Center for Biotechnology Information. "PubChem Compound Summary for CID 638793, Gonadorelin" PubChem
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For detailed information about Gonadorelin by Beligas Pharmaceuticals, consult with your doctor or healthcare professional.
National Center for Biotechnology Information. "PubChem Compound Summary for CID 638793, Gonadorelin" PubChem
National Center for Biotechnology Information. "PubChem Compound Summary for CID 638793, Gonadorelin" PubChem
National Center for Biotechnology Information. "PubChem Compound Summary for CID 638793, Gonadorelin" PubChem